Climb Biotherapeutics, Inc. (CLYM)
Market Closed
18 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
14. 05
-0.01
-0.0711%
$
805.12M Market Cap
- P/E Ratio
- Div Yield
4.05M Volume
0 Eps
$ 14.06
Previous Close 
Want to track CLYM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Climb Biotherapeutics, Inc. (CLYM) Statistics
Valuation metrics
Market Cap 805.12M
Enterprise value 761.75M
Trailing P/E (ttm) -16.93
Forward P/E -
PEG ratio 0.83
Price/Sales (ttm) -
Price/Book (mrq) 4.47
Enterprise Value/Revenue -
Enterprise Value/EBITDA -12.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.05M
Average volume (90 days) 1.93M
Price summary
52-Week low 1.54
52-Week high 18.33
Beta -
50-Day moving average 14.12
200-Day moving average 9.71
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.23%
Return on equity -0.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.76
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.4
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 31.45%
Book value per share (mrq) 3.15
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
